SARS-CoV-2 Mpro-IN-20

SARS-CoV-2 Mpro-IN-20 (compound MPI100) is a SARS-CoV-2 main protease inhibitor. SARS-CoV-2 Mpro-IN-20 shows antiviral activity with the EC50 of 3.4 μM[1].

Product Specifications

UNSPSC

12352005

Target

SARS-CoV

Type

Reference compound

Related Pathways

Anti-infection

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/sars-cov-2-mpro-in-20.html

Smiles

O=C(N1[C@H](C(N[C@@H](C[C@H]2C(NCC2)=O)C=O)=O)[C@@]3([H])C(C)(C)[C@@]3([H])C1)[C@@H](NC(OCC4=CC=CC=C4)=O)CC5CCCCC5

Molecular Formula

C32H44N4O6

Molecular Weight

580.71

References & Citations

[1]Blankenship LR, et al. SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme. ACS Med Chem Lett. 2024;15 (6) :950-957. Published 2024 May 20.